Latest filing published 10 Sept 2026 for Bicara Therapeutics Inc., €57k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Ryan Cohlhepp appears in our data through filings on Bicara Therapeutics Inc. shares, published by SEC (Form 4). Over a trading history stretching from 6 October 2025 to 8 September 2026, the count stands at 23 filings.
Sales make up the whole of the open-market record (11 sales, €1.8M). Besides market trades, the filings include 12 option exercises. So far in 2026, the count stands at no purchases and 11 sales.
The record was last updated on 10 September 2026 with an option exercise (€57k) in Bicara Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations